rs143218779
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_Strong
The NM_000492.4(CFTR):c.1407G>A(p.Met469Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,452,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M469V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CFTR | NM_000492.4 | c.1407G>A | p.Met469Ile | missense_variant | Exon 11 of 27 | ENST00000003084.11 | NP_000483.3 | |
| CFTR-AS1 | NR_149084.1 | n.221+1255C>T | intron_variant | Intron 2 of 2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251252 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1452206Hom.: 0 Cov.: 28 AF XY: 0.00000138 AC XY: 1AN XY: 723208 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The CFTR c.1407G>A; p.Met469Ile variant (rs143218779) is reported in the literature in several individuals affected with congenital bilateral absence of the vas deferens (CBAVD) (Chiang 2019, Wu 2005). This variant found on only a single chromosome in the Genome Aggregation Database (1/251252 alleles), indicating it is not a common polymorphism. The methionine at codon 469 is highly conserved, but computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. However, another amino acid substitution at this codon (p.Met469Val) has been reported in individuals with CBAVD or pancreatitis (Lu 2013, Lu 2014, Xiao 2017). Nonetheless, due to limited information, the clinical significance of the p.Met469Ile variant is uncertain at this time. References: Chiang HS et al. The role of SLC9A3 in Taiwanese patients with congenital bilateral absence of vas deferens (CBAVD). J Formos Med Assoc. 2019 Feb 20. pii: S0929-6646(18)30529-1. Lu S et al. Association of cystic fibrosis transmembrane-conductance regulator gene mutation with negative outcome of intracytoplasmic sperm injection pregnancy in cases of congenital bilateral absence of vas deferens. Fertil Steril. 2014 May;101(5):1255-60. Lu S et al. Different cystic fibrosis transmembrane conductance regulator mutations in Chinese men with congenital bilateral absence of vas deferens and other acquired obstructive azoospermia. Urology. 2013 Oct;82(4):824-8. Wu CC et al. Mutation spectrum of the CFTR gene in Taiwanese patients with congenital bilateral absence of the vas deferens. Hum Reprod. 2005 Sep;20(9):2470-5. Xiao Y et al. Targeted Gene Next-Generation Sequencing in Chinese Children with Chronic Pancreatitis and Acute Recurrent Pancreatitis. J Pediatr. 2017 Dec;191:158-163.e3. -
CFTR-related disorder Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at